Literature DB >> 16150254

Headache as a side effect of combination estrogen-progestin oral contraceptives: a systematic review.

Elizabeth W Loder1, Dawn C Buse, Joan R Golub.   

Abstract

OBJECTIVE: We conducted a 2-part systematic review of published studies to examine the evidence that combination oral contraceptives can aggravate or cause headache. STUDY
DESIGN: We used trials with a control group to assess headache risk that was attributable to oral contraceptive use and prospective cohort trials to answer important clinical questions about the natural history and treatment response of headache that occurs with oral contraceptive use.
RESULTS: Because of differences in study populations, oral contraceptive formulations, trial end points and trial duration, it was not possible to pool data; but the evidence supports several conclusions. There is little indication that oral contraceptives have a clinically important effect on headache activity in most women.
CONCLUSION: Headache that occurs during early cycles of oral contraceptive use tends to improve or disappear with continued use. No evidence supports the common clinical practice of switching oral contraceptives to treat headache; however, manipulating the extent or duration of estrogen withdrawal may provide benefit.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16150254     DOI: 10.1016/j.ajog.2004.12.089

Source DB:  PubMed          Journal:  Am J Obstet Gynecol        ISSN: 0002-9378            Impact factor:   8.661


  12 in total

Review 1.  Hormonal contraception and migraine: clinical considerations.

Authors:  Stephanie S Faubion; Petra M Casey; Lynne T Shuster
Journal:  Curr Pain Headache Rep       Date:  2012-10

2.  Hormonal manipulation strategies in the management of menstrual migraine and other hormonally related headaches.

Authors:  Lynne T Shuster; Stephanie S Faubion; Richa Sood; Petra M Casey
Journal:  Curr Neurol Neurosci Rep       Date:  2011-04       Impact factor: 5.081

3.  Oral contraceptives in migraine therapy.

Authors:  Gianni Allais; Ilaria Castagnoli Gabellari; Cristina De Lorenzo; Ornella Mana; Chiara Benedetto
Journal:  Neurol Sci       Date:  2011-05       Impact factor: 3.307

4.  Hormonal contraceptive options for women with headache: a review of the evidence.

Authors:  Andrea G Edlow; Deborah Bartz
Journal:  Rev Obstet Gynecol       Date:  2010

Review 5.  Adolescent issues in migraine: a focus on menstrual migraine.

Authors:  Christine L Lay; Susan W Broner
Journal:  Curr Pain Headache Rep       Date:  2008-10

6.  Oral contraceptive-induced menstrual migraine. Clinical aspects and response to frovatriptan.

Authors:  Gianni Allais; Gennaro Bussone; Gisella Airola; Paola Borgogno; Ilaria Castagnoli Gabellari; Cristina De Lorenzo; Elena Pavia; Chiara Benedetto
Journal:  Neurol Sci       Date:  2008-05       Impact factor: 3.307

Review 7.  Migraine in women: the role of hormones and their impact on vascular diseases.

Authors:  Simona Sacco; Silvia Ricci; Diana Degan; Antonio Carolei
Journal:  J Headache Pain       Date:  2012-02-26       Impact factor: 7.277

8.  Positive effects of the progestin desogestrel 75 μg on migraine frequency and use of acute medication are sustained over a treatment period of 180 days.

Authors:  Gabriele S Merki-Feld; Bruno Imthurn; Ronald Langner; Burkhardt Seifert; Andreas R Gantenbein
Journal:  J Headache Pain       Date:  2015-05-01       Impact factor: 7.277

Review 9.  Hormonal contraception in women with migraine: is progestogen-only contraception a better choice?

Authors:  Rossella E Nappi; Gabriele S Merki-Feld; Erica Terreno; Alice Pellegrinelli; Michele Viana
Journal:  J Headache Pain       Date:  2013-08-01       Impact factor: 7.277

10.  Hormonal contraceptives and risk of ischemic stroke in women with migraine: a consensus statement from the European Headache Federation (EHF) and the European Society of Contraception and Reproductive Health (ESC).

Authors:  Simona Sacco; Gabriele S Merki-Feld; Karen Lehrmann Ægidius; Johannes Bitzer; Marianne Canonico; Tobias Kurth; Christian Lampl; Øjvind Lidegaard; E Anne MacGregor; Antoinette MaassenVanDenBrink; Dimos-Dimitrios Mitsikostas; Rossella Elena Nappi; George Ntaios; Per Morten Sandset; Paolo Martelletti
Journal:  J Headache Pain       Date:  2017-10-30       Impact factor: 7.277

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.